King Vision vs Macintosh Laryngoscopy for Intubation Time in Novice Users
KVVL
Comparison of the King Vision Channeled Videolaryngoscope and Conventional Laryngoscopy for Endotracheal Intubation Time in Novice Users: A Prospective, Randomised Controlled Trial
2 other identifiers
interventional
70
1 country
1
Brief Summary
This study evaluated two different devices used for placing a breathing tube (endotracheal intubation) in adult patients undergoing elective surgery. The aim was to compare the King Vision videolaryngoscope, which has a camera and a guiding channel for the tube, with the traditional Macintosh laryngoscope, which allows doctors to look directly at the vocal cords. The study focused on how long it takes to successfully insert the tube, the need for additional maneuvers during the procedure, and the overall success rate of first attempts. The procedures were performed by novice operators under supervision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedSeptember 15, 2025
September 1, 2025
7 months
September 8, 2025
September 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Time to successful endotracheal intubation (seconds)
Measured from insertion of the laryngoscope blade between the patient's incisors until removal of the blade after correct placement of the endotracheal tube, confirmed by capnography.
During intubation (intraoperative period, approximately 1-2 minutes)
Study Arms (2)
Group K
EXPERIMENTALChannelled blade of KVVL
Group M
ACTIVE COMPARATORMacintosh laryngoscope
Interventions
King Vision Videolaryngoscope (KVVL) is one of the new indirect laryngoscopes with disposable (either with channeled or non-channeled) blades .Both designs include an anti-fog lens coating . The channelled KVVL has a rigid blade with an integrated channel for introducing the endotracheal tube. The height and width of the standard non-channeled and channeled blades are 13 mm and 26 mm vs 18 mm and 29 mm, respectively. The KVVL has a unique design and high-quality image . It has a camera that enables a clear view of the glottis. It is a solid, portable, battery-operated device with an organic LED display for video laryngoscopy . It allows better glottis visualization and Cormack Lehane score than DL. Compared with Airtraq, the KVVL has wide field of view (160° vs 80° respectively) and potentially shortens the time to tracheal intubation .
In clinical practice, direct laryngoscopy (DL) with either a curved (Macintosh) or straight (Miller) blade is a well-known and reliable technique in the hands of an experienced operator.
Eligibility Criteria
You may qualify if:
- Adult patients (≥18 years old) scheduled for elective surgery under general anesthesia requiring orotracheal intubation
- American Society of Anesthesiologists (ASA) physical status I-II
- Mallampati airway classification I-II
- Written informed consent obtained from the patient
You may not qualify if:
- Predicted or known difficult airway: Mallampati III-IV, inter-incisor distance \<2.5 cm, thyromental distance \<6 cm, limited cervical spine mobility
- History of difficult intubation or need for awake/rapid-sequence intubation
- Upper airway pathology (tumour, trauma, infection), limited mouth opening, or craniofacial anomalies
- Emergency surgery, high aspiration risk, or full stomach
- Severe cardiopulmonary instability (e.g., shock, severe hypoxaemia)
- Pregnancy or breastfeeding
- BMI \>35 kg/m² (if your protocol excludes obesity; remove if not applicable)
- Participation refusal or inability to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hitit Universitylead
- Izmir City Hospitalcollaborator
Study Sites (1)
Izmir City Hospital
Izmir, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 15, 2025
Study Start
January 1, 2023
Primary Completion
July 31, 2023
Study Completion
January 1, 2024
Last Updated
September 15, 2025
Record last verified: 2025-09